Lysostaphin cream

Drug Profile

Lysostaphin cream

Alternative Names: BSYX-L210; BSYX-L310; Lysostaphin intranasal cream; Lysostaphin topical cream

Latest Information Update: 15 Sep 2015

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Nutrition 21
  • Developer Biosynexus
  • Class Antibacterials; Metalloendopeptidases
  • Mechanism of Action
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Discontinued Staphylococcal infections

Most Recent Events

  • 16 Oct 2003 Phase-I/II clinical trials in Staphylococcal infections in USA (Intranasal)
  • 16 Oct 2003 Data from a media release have been added to the adverse events and Bacterial Infections therapeutic trials sections
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top